Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marika Pagé"'
Autor:
Maria Ochoa, Roman Jurencak, Kevin Smit, Sasha Carsen, Sarah L. Sawyer, Marie-Eve Robinson, Karine Khatchadourian, Hooi Peng Cheng, Marika Pagé, Joel Werier, Leanne Marie Ward
Publikováno v:
Bone Reports, Vol 19, Iss , Pp 101695- (2023)
We describe the clinical evolution of a patient with tumoral calcinosis due to a pathogenic variant in the GALNT3 gene presented with a large mass overlying her left hip associated complicated by inflammatory flares. Therapy (sevelamer, acetazolamide
Externí odkaz:
https://doaj.org/article/8263dfb12562465cac43ce38dde4da34
Autor:
Maria Ochoa, Ashlee Yang, Carrie Kollias, Christina Bakir, Sasha Carsen, Joanna Lazier, A. Micheil Innes, Marika Pagé, Jonathan Dawrant, Marie-Eve Robinson, Khaldoun Koujok, Nazih Shenouda, Frank Rauch, Leanne M. Ward
Publikováno v:
Bone Reports, Vol 18, Iss , Pp 101663- (2023)
Osteochondritis dissecans (OCD) is a disease of the joints characterized by idiopathic focal subchondral lesions. Aggrecan, a proteoglycan encoded by the ACAN gene, is important for cartilage structure and function. We describe the clinical evolution
Externí odkaz:
https://doaj.org/article/60811d835fcf43cc96c2f7f728bb368d
Autor:
Umar Akel, Marie‐Eve Robinson, Joel Werier, Raja Rampersaud, Kawan Rakhra, Donna Johnston, Victor N Konji, Jinhui Ma, Marika Pagé, Mary Ann Matzinger, Leanne M Ward
Publikováno v:
JBMR Plus, Vol 3, Iss 9, Pp n/a-n/a (2019)
ABSTRACT Giant cell tumors of bone (GCTB) may be difficult to resect because of size or location. We describe two adolescents who were treated with denosumab and followed for tumoral and biochemical responses. Denosumab was effective in achieving suf
Externí odkaz:
https://doaj.org/article/461780fbcd994c6a8b9ada751d61315b
Autor:
Lillian Abebe, Kim Phung, Marie-Eve Robinson, Richelle Waldner, Sasha Carsen, Kevin Smit, Andrew Tice, Joanna Lazier, Christine Armour, Marika Page, Saunya Dover, Frank Rauch, Khaldoun Koujok, Leanne M. Ward
Publikováno v:
Bone Reports, Vol 20, Iss , Pp 101725- (2024)
Cutaneous-skeletal hypophosphatemia syndrome (CSHS) is a rare bone disorder featuring fibroblast growth factor-23 (FGF23)-mediated hypophosphatemic rickets. We report a 2-year, 10-month-old girl with CSHS treated with burosumab, a novel human monoclo
Externí odkaz:
https://doaj.org/article/58102a7ca5c2489db0f8dddd4635a9a1